ICON Shares Outstanding 2010-2025 | ICLR
ICON shares outstanding history from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- ICON shares outstanding for the quarter ending March 31, 2025 were 0.081B, a 2.79% decline year-over-year.
- ICON 2024 shares outstanding were 0.083B, a 0.38% increase from 2023.
- ICON 2023 shares outstanding were 0.083B, a 0.3% increase from 2022.
- ICON 2022 shares outstanding were 0.082B, a 21.16% increase from 2021.
| ICON Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 83 |
| 2023 | 83 |
| 2022 | 82 |
| 2021 | 68 |
| 2020 | 53 |
| 2019 | 54 |
| 2018 | 55 |
| 2017 | 55 |
| 2016 | 56 |
| 2015 | 60 |
| 2014 | 63 |
| 2013 | 62 |
| 2012 | 60 |
| 2011 | 61 |
| 2010 | 61 |
| 2009 | 60 |
| ICON Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 81 |
| 2024-12-31 | 83 |
| 2024-09-30 | 83 |
| 2024-06-30 | 83 |
| 2024-03-31 | 83 |
| 2023-12-31 | 83 |
| 2023-09-30 | 83 |
| 2023-06-30 | 83 |
| 2023-03-31 | 83 |
| 2022-12-31 | 82 |
| 2022-09-30 | 82 |
| 2022-06-30 | 82 |
| 2022-03-31 | 83 |
| 2021-12-31 | 68 |
| 2021-09-30 | 81 |
| 2021-06-30 | 53 |
| 2021-03-31 | 53 |
| 2020-12-31 | 53 |
| 2020-09-30 | 53 |
| 2020-06-30 | 53 |
| 2020-03-31 | 54 |
| 2019-12-31 | 54 |
| 2019-09-30 | 55 |
| 2019-06-30 | 54 |
| 2019-03-31 | 54 |
| 2018-12-31 | 55 |
| 2018-09-30 | 55 |
| 2018-06-30 | 55 |
| 2018-03-31 | 55 |
| 2017-12-31 | 55 |
| 2017-09-30 | 55 |
| 2017-06-30 | 55 |
| 2017-03-31 | 55 |
| 2016-12-31 | 56 |
| 2016-09-30 | 57 |
| 2016-06-30 | 57 |
| 2016-03-31 | 56 |
| 2015-12-31 | 60 |
| 2015-09-30 | 60 |
| 2015-06-30 | 62 |
| 2015-03-31 | 62 |
| 2014-12-31 | 62 |
| 2014-09-30 | 63 |
| 2014-06-30 | 63 |
| 2014-03-31 | 63 |
| 2013-12-31 | 63 |
| 2013-09-30 | 62 |
| 2013-06-30 | 62 |
| 2013-03-31 | 61 |
| 2012-12-31 | 61 |
| 2012-09-30 | 60 |
| 2012-06-30 | 61 |
| 2012-03-31 | 61 |
| 2011-12-31 | 61 |
| 2011-09-30 | 61 |
| 2011-06-30 | 61 |
| 2011-03-31 | 61 |
| 2010-12-31 | 61 |
| 2010-09-30 | 61 |
| 2010-06-30 | 61 |
| 2010-03-31 | 60 |
| 2009-12-31 | 60 |
| 2009-09-30 | 60 |
| 2009-06-30 | 60 |
| 2009-03-31 | 60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.225B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $133.694B | 25.08 |
| Elevance Health (ELV) | United States | $90.401B | 11.66 |
| CVS Health (CVS) | United States | $78.570B | 9.77 |
| Cencora (COR) | United States | $56.472B | 19.65 |
| DiDi Global (DIDIY) | China | $22.450B | 34.07 |
| Natera (NTRA) | United States | $20.631B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.588B | 13.33 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.514B | 0.00 |
| CochLear (CHEOY) | Australia | $11.382B | 0.00 |
| Revvity (RVTY) | United States | $10.588B | 18.22 |
| Viatris (VTRS) | United States | $9.953B | 3.42 |
| Doximity (DOCS) | United States | $9.475B | 44.13 |
| Avantor (AVTR) | United States | $8.552B | 12.43 |
| HealthEquity (HQY) | United States | $8.545B | 42.04 |
| Medpace Holdings (MEDP) | United States | $8.501B | 22.58 |
| Sonic Healthcare (SKHHY) | Australia | $8.263B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.630B | 12.99 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.137B | 38.29 |
| Bausch + Lomb (BLCO) | Canada | $3.955B | 23.31 |
| Sotera Health (SHC) | United States | $3.503B | 19.90 |
| Alignment Healthcare (ALHC) | United States | $3.033B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.905B | 37.78 |
| Concentras Parent (CON) | United States | $2.803B | 16.20 |
| Organon (OGN) | United States | $2.191B | 2.33 |
| Ardent Health Partners (ARDT) | United States | $2.137B | 9.11 |
| GeneDx Holdings (WGS) | United States | $1.934B | 74.48 |
| Premier (PINC) | United States | $1.899B | 14.41 |
| Progyny (PGNY) | United States | $1.816B | 39.98 |
| PACS (PACS) | United States | $1.506B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.354B | 27.07 |
| Pediatrix Medical (MD) | United States | $1.303B | 9.91 |
| Teladoc Health (TDOC) | United States | $1.223B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.037B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| Agilon Health (AGL) | United States | $0.973B | 0.00 |
| CareDx (CDNA) | United States | $0.949B | 14.83 |
| Nutex Health (NUTX) | United States | $0.941B | 14.21 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.722B | 4.86 |
| InnovAge Holding (INNV) | United States | $0.554B | 0.00 |
| Enhabit (EHAB) | United States | $0.528B | 43.46 |
| Auna S.A (AUNA) | Luxembourg | $0.506B | 11.40 |
| LifeMD (LFMD) | United States | $0.489B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.403B | 0.00 |
| SBC Medicals (SBC) | United States | $0.360B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.204B | 0.00 |
| Oncology Institute (TOI) | United States | $0.202B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| KindlyMD (KDLY) | United States | $0.137B | 0.00 |
| DocGo (DCGO) | United States | $0.131B | 21.33 |
| So-Young (SY) | China | $0.089B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.058B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |